Esperion Therapeutics, Inc. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Esperion Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Esperion Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 23.7 %, a 59.2% decline year-over-year.
  • Esperion Therapeutics, Inc. annual Return On Equity for 2023 was 53.4 %, a 33.8% decline from 2022.
  • Esperion Therapeutics, Inc. annual Return On Equity for 2022 was 80.7 %, a 15.1% decline from 2021.
  • Esperion Therapeutics, Inc. annual Return On Equity for 2021 was 95 %, a 91.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 53.4 -27.2 -33.8% Jan 1, 2023 Dec 31, 2023
2022 80.7 -14.3 -15.1% Jan 1, 2022 Dec 31, 2022
2021 95 -1.01K -91.4% Jan 1, 2021 Dec 31, 2021
2020 1.11K +1.2K Jan 1, 2020 Dec 31, 2020
2019 -98.9 +35.4 +26.3% Jan 1, 2019 Dec 31, 2019
2018 -134 -57.5 -74.8% Jan 1, 2018 Dec 31, 2018
2017 -76.8 -47.7 -164% Jan 1, 2017 Dec 31, 2017
2016 -29.2 -12.6 -76.3% Jan 1, 2016 Dec 31, 2016
2015 -16.5 +30.4 +64.8% Jan 1, 2015 Dec 31, 2015
2014 -47 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.